These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8697891)
1. Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong. Chan TH; Ho SS; Lai CK; Cheung SW; Chan RC; Cheng AF; Chan CH Chemotherapy; 1996; 42(2):150-6. PubMed ID: 8697891 [TBL] [Abstract][Full Text] [Related]
2. Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis. Lam WK; Chau PY; So SY; Leung YK; Chan JC; Ip M; Sham MK Respir Med; 1989 Jul; 83(4):299-303. PubMed ID: 2692094 [TBL] [Abstract][Full Text] [Related]
3. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Bilton D; Henig N; Morrissey B; Gotfried M Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030 [TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis. Langan CE; Cranfield R; Breisch S; Pettit R J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875 [TBL] [Abstract][Full Text] [Related]
6. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200 [TBL] [Abstract][Full Text] [Related]
7. Controlled prospective study of oral ciprofloxacin versus amoxycillin/clavulanic acid in chronic suppurative otitis media in adults. Legent F; Bordure P; Beauvillain C; Berche P Chemotherapy; 1994; 40 Suppl 1():16-23. PubMed ID: 7805426 [TBL] [Abstract][Full Text] [Related]
8. Effect of oral antibiotics on lung mucociliary clearance during exacerbation of chronic obstructive pulmonary disease. Hasani A; Pavia D; Rotondetto S; Clarke SW; Spiteri MA; Agnew JE Respir Med; 1998 Mar; 92(3):442-7. PubMed ID: 9692103 [TBL] [Abstract][Full Text] [Related]
9. A double-blind randomized study comparing ofloxacin and amoxicillin in treating infective episodes in bronchiectasis. Lam WK; Chau PY; So SY; Leung YK; Chan JC; Sham MK Infection; 1986; 14 Suppl 4():S290-2. PubMed ID: 3546147 [TBL] [Abstract][Full Text] [Related]
10. Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation. Philpott-Howard J; Burroughs A; Fisher N; Hastings M; Kibbler C; Mutimer D; Patch D; Rolando N; Wade J; Wendon J; O'Grady J J Antimicrob Chemother; 2003 Dec; 52(6):993-1000. PubMed ID: 14585863 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis. Rayner CF; Tillotson G; Cole PJ; Wilson R J Antimicrob Chemother; 1994 Jul; 34(1):149-56. PubMed ID: 7961201 [TBL] [Abstract][Full Text] [Related]
12. Treatment of acute exacerbations of chronic obstructive airways disease--a comparison of amoxycillin and ciprofloxacin. Basran GS; Joseph J; Abbas AM; Hughes C; Tillotson GS J Antimicrob Chemother; 1990 Dec; 26 Suppl F():19-24. PubMed ID: 2292540 [TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis. Grassi C; Salvatori E; Rosignoli MT; Dionisio P; Respiration; 2002; 69(3):217-22. PubMed ID: 12097764 [TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract]. Chuchalin AG; Novikov IuK; Avdeev SN; BelevskiÄ AS Antibiot Khimioter; 1997; 42(6):34-8. PubMed ID: 9313057 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin. Gleadhill IC; Ferguson WP; Lowry RC J Antimicrob Chemother; 1986 Nov; 18 Suppl D():133-8. PubMed ID: 3804901 [TBL] [Abstract][Full Text] [Related]
16. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis. Chorepsima S; Kechagias KS; Kalimeris G; Triarides NA; Falagas ME Drug Des Devel Ther; 2018; 12():4059-4066. PubMed ID: 30568427 [TBL] [Abstract][Full Text] [Related]
17. Cefaclor and amoxycillin in the treatment of infective exacerbations of chronic bronchitis. Law MR; Holt HA; Reeves DS; Hodson ME J Antimicrob Chemother; 1983 Jan; 11(1):83-8. PubMed ID: 6337988 [TBL] [Abstract][Full Text] [Related]
18. Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis. Ricevuti G; Mazzone A; Uccelli E; Gazzani G; Fregnan GB Thorax; 1988 Aug; 43(8):585-90. PubMed ID: 3051508 [TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study. Wilson R; Welte T; Polverino E; De Soyza A; Greville H; O'Donnell A; Alder J; Reimnitz P; Hampel B Eur Respir J; 2013 May; 41(5):1107-15. PubMed ID: 23018904 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of lower respiratory tract infections in the elderly]. Komarova VP; Belousov IuB; Sokolov AV; Tishchenkova IF; Efremenkova OV Antibiot Khimioter; 1997; 42(12):19-24. PubMed ID: 9480649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]